Navigation Links
ECNP expresses concern at AstraZeneca neuroscience pull-out

The European College of Neuropsychopharmacology expresses its deep concern at the recently announced withdrawal by AstraZeneca from neuroscience drug research. AstraZeneca's pull-out is especially disturbing given that it follows a series of similar withdrawals in the last two years by major pharmaceutical companies. There is a growing sense that neuroscience in Europe is now facing a severe crisis.

"Disorders of the brain are Europe's pre-eminent health care concern of the future," says ECNP president, Joseph Zohar, professor of psychiatry at Tel Aviv University. "Medications, properly targeted, are in almost all cases the key to effective treatment. To have a major player like AstraZeneca, with an outstanding history of innovation and development in disorders of the brain, pull out of the field in this way will inevitably affect Europeans' access to high-quality medications in the future. This is not good news for patients."

Research sponsored by ECNP shows that more than a third of all Europeans experience some form of mental disorder in any given year, at a total cost to the region of some 800 billion per annum. The direct medical costs of these disorders constitute almost a quarter of the European Union's total health care expenditure, with indirect costs from work absences to enforced early retirement almost twice as much again. The social and emotional costs are incalculable.

AstraZeneca's pull-out is especially disturbing given that it follows a series of similar withdrawals in the last two years by major pharmaceutical companies, including GlaxoSmithKline, Pfizer, Merck, Sanofi and Novartis, who have all significantly downsized their neuroscience commitment. There is a growing sense that neuroscience in Europe is now facing a severe crisis.

"Neuroscience has long been one of Europe's outstanding scientific strengths," says ECNP secretary, Sven Ove gren, professor of neuroscience at Sweden's Karolinska Institutet. "The loss of hundreds of research positions in the field is an enormous blow. Coming on top of similar closures at almost all of Europe's big pharma companies, it's a very worrying development. What's now urgently needed is united action from all those interested in Europe's neuroscientific future to ensure that the region's neuroscience research base of which pharma is an indispensible part does not suffer permanent and possibly irreversible damage."


Contact: Sonja Mak
European College of Neuropsychopharmacology

Related medicine news :

1. Supportive of intent of ACO proposed rule, ACP expresses concern
2. IHRSA Expresses Its Ardent Support of America's First-Ever National Physical Activity Plan and Accepts Role as Co-Chair of Implementation Sub-Committee
3. U.S. African Chamber of Commerce President Expresses Concern over Health Care Bill
4. Cases of Tamiflu-Resistant Flu Concern Experts
5. Women should still be concerned about hormone replacement therapy, say McMaster researchers
6. Buildup of Newer Flame Retardants Concerns Scientists
7. Potential concern about drugs in clinical trial
8. Group sex among adolescents a public health concern, new study says
9. 15 new conservation concerns
10. Concerns about teen sexting overblown, according to new UNH research
11. Internists address dual concerns of privacy and protection of health data
Post Your Comments:
(Date:10/13/2015)... ... ... "My friend's son suffers from eczema, and he had a horrible habit ... Platteville, Colo. "I came up with this kit as a way to prevent children ... child from rubbing or scratching his or her face. This protects sensitive skin from ...
(Date:10/13/2015)... ... , ... ProText Kinetic Panel is a typography creation tool made for use ... energetic text animations in any layout without the use of keyframes. Using ProText Kinetic ... stylize the text. With intuitive on-screen controls, users can re-position and scale the text. ...
(Date:10/13/2015)... ... October 13, 2015 , ... Relay (, ... application, announced today a significant contract that will provide its award-winning private messaging ... build on the growing success of its Relay program, IBX Wire™, which now ...
(Date:10/13/2015)... ... October 13, 2015 , ... Leading ... Singal's newly launched "Publish Academy" training course . Singal's new program, in ... enrollment today, and marketers around the Internet are weighing in with reviews. , ...
(Date:10/13/2015)... ... October 13, 2015 , ... T-System ... with more than 59,000 emergency department visits per year, today announced the successful ... to help improve clinical, operational and financial outcomes. , In less ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 2015  Kay Elledge, M.D., an established South ... of Obstetrics and Gynecology (FACOG) for the past ... Genuine Self Medical Laser Center where she provides ... of Breast Cancer Awareness Month , the ... MonaLisa Touch treatments initiated in the month ...
(Date:10/13/2015)... 13, 2015  Human Longevity, Inc. (HLI), the genomics-based, ... announced today the launch of the company,s first Health ... the potential to transform healthcare. The inaugural Health Nucleus ... , at HLI,s headquarters facility. More Health Nucleus facilities ... and International cities. --> ...
(Date:10/13/2015)... SAN DIEGO , Oct. 13, 2015 /PRNewswire/ ... bioelectronics for use in research and diagnostics, announces ... of $1.6 million led by Serra Ventures. ... Nanomed,s mission is providing low-cost, easy-to-use monitoring and ... personal health decisions. The funding round will enable ...
Breaking Medicine Technology: